Comparison of Axonics Modulation Technologies Inc. (AXNX) and CHF Solutions Inc. (NASDAQ:CHFS)

Both Axonics Modulation Technologies Inc. (NASDAQ:AXNX) and CHF Solutions Inc. (NASDAQ:CHFS) are each other’s competitor in the Medical Appliances & Equipment industry. Thus the contrast of their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Axonics Modulation Technologies Inc. N/A 2048.35 27.75M -0.98 0.00
CHF Solutions Inc. 4.33M 1.04 28.65M -14.45 0.00

Table 1 shows top-line revenue, earnings per share (EPS) and valuation of the two companies.

Profitability

Table 2 represents Axonics Modulation Technologies Inc. (NASDAQ:AXNX) and CHF Solutions Inc. (NASDAQ:CHFS)’s return on assets, net margins and return on equity.

Net Margins Return on Equity Return on Assets
Axonics Modulation Technologies Inc. 0.00% 0% 0%
CHF Solutions Inc. -661.66% -267.6% -226.7%

Liquidity

The current Quick Ratio of Axonics Modulation Technologies Inc. is 8.3 while its Current Ratio is 8.7. Meanwhile, CHF Solutions Inc. has a Current Ratio of 5.6 while its Quick Ratio is 4.6. Axonics Modulation Technologies Inc. is better positioned to pay off its short-term and long-term debts than CHF Solutions Inc.

Insider & Institutional Ownership

The shares of both Axonics Modulation Technologies Inc. and CHF Solutions Inc. are owned by institutional investors at 46.52% and 19.4% respectively. Insiders owned 3.9% of Axonics Modulation Technologies Inc. shares. Competitively, CHF Solutions Inc. has 0.4% of it’s share owned by insiders.

Performance

In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Axonics Modulation Technologies Inc. 21.97% 3.01% 0% 0% 0% 7.48%
CHF Solutions Inc. -20.9% -35.78% -44.44% -74.36% -77.35% -79.77%

For the past year Axonics Modulation Technologies Inc. had bullish trend while CHF Solutions Inc. had bearish trend.

Summary

Axonics Modulation Technologies Inc. beats on 8 of the 9 factors CHF Solutions Inc.

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.